Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival
Upasana Das Adhikari, George Eng, M Fărcăşanu, Laura E. Avena, Manish C. Choudhary, Virginia A. Triant, Meaghan Flagg, Abigail E. Schiff, Isabella Gomez, Leah Froehle, Thomas Diefenbach, Larance Ronsard, Daniel Lingwood, Grace C. Lee, S. Rabi, Derek J. Erstad, George C. Velmahos, Jonathan Z. Li, Richard A. Hodin, James R. Stone, Anna N. Honko, Anthony Griffiths, Ömer Yılmaz, Douglas S. Kwon
Abstract
The clinical significance of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) RNA in stool remains uncertain. We found that extrapulmonary dissemination of infection to the gastrointestinal tract, assessed by the presence of SARS-CoV-2 RNA in stool, is associated with decreased coronavirus disease 2019 (COVID-19) survival. Measurement of SARS-CoV-2 RNA in stool may have utility for clinical risk assessment.